Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.
Exercise induced rhabdomyolysis is a complication of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (TFP) deficiency that frequently leads to exercise avoidance. Dietary therapy for most subjects includes medium-chain triglyceride (MCT) supplementation but analysis of diet records indicates that the majority of patients consume oral MCT only with breakfast and at bedtime. We hypothesized that MCT immediately prior to exercise would provide an alternative fuel source during that bout of exercise and improve exercise tolerance in children with LCHAD deficiency. Nine subjects completed two 45 min moderate intensity (60-70% predicted maximum heart rate (HR)) treadmill exercise tests. Subjects were given 4 oz of orange juice alone or orange juice and 0.5 g MCT per kg lean body mass, 20 min prior to exercise in a randomized cross-over design. ECG and respiratory gas exchange including respiratory quotient (RQ) were monitored. Blood levels of acylcarnitines, creatine kinase, lactate, and beta-hydroxybutyrate were measured prior to and immediately after exercise, and again following 20 min rest. Creatine kinase and lactate levels did not change with exercise. There was no significant difference in RQ between the two exercise tests but there was a decrease in steady-state HR following MCT supplementation. Cumulative long-chain 3-hydroxyacylcarnitines were 30% lower and beta-hydroxybutyrate was three-fold higher after the MCT-pretreated exercise test compared to the test with orange juice alone. Coordinating MCT supplementation with periods of increased activity may improve the metabolic control of children with LCHAD and TFP deficiency following exercise.
Gillingham
Melanie B
MB
Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239-3098, USA. gillingm@ohsu.edu <gillingm@ohsu.edu>
Scott
Bradley
B
Elliott
Diane
D
Harding
Cary O
CO
D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000172:deficiency*; D020155:3-Hydroxybutyric Acid / Q000097:blood; D000293:Adolescent; D002331:Carnitine / Q000031:analogs & derivatives / Q000097:blood; D002648:Child; D003402:Creatine Kinase / Q000097:blood; D015444:Exercise; D005260:Female; D006801:Humans; D019344:Lactic Acid / Q000097:blood; D063989:Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase; D008297:Male; D063991:Mitochondrial Trifunctional Protein; D009097:Multienzyme Complexes / Q000172:deficiency*; D012206:Rhabdomyolysis / Q000201:enzymology*; D014280:Triglycerides / Q000008:administration & dosage / Q000378:metabolism*
D009097:Multienzyme Complexes; D014280:Triglycerides; C116917:acylcarnitine; D019344:Lactic Acid; D015094:3-Hydroxyacyl CoA Dehydrogenases; D063989:Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase; D063991:Mitochondrial Trifunctional Protein; D003402:Creatine Kinase; D002331:Carnitine; D020155:3-Hydroxybutyric Acid